Sequenom Stock Price, News & Analysis (NASDAQ:SQNM)

$2.39 0.00 (0.00 %)
(As of 03/18/2018 04:00 PM ET)
Previous Close$2.39
Today's Range$2.39 - $2.39
52-Week Range$0.82 - $2.53
Average Volume1.27 million shs
Market Capitalization$283.80 million
P/E Ratio-6.83
Dividend YieldN/A

About Sequenom (NASDAQ:SQNM)

Sequenom logoSequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Receive SQNM News and Ratings via Email

Sign-up to receive the latest news and ratings for SQNM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Diagnostic & Testing Equipment
Sub-IndustryLife Sciences Tools & Services


Debt-to-Equity Ratio-2.35%
Current Ratio3.35%
Quick Ratio3.16%


Trailing P/E Ratio-6.82857142857143
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($0.35)
Net IncomeN/A
Net Margins-21.54%
Return on EquityN/A
Return on Assets-25.05%


Outstanding Shares119,220,000

Sequenom (NASDAQ:SQNM) Frequently Asked Questions

What is Sequenom's stock symbol?

Sequenom trades on the NASDAQ under the ticker symbol "SQNM."

How were Sequenom's earnings last quarter?

Sequenom, Inc. (NASDAQ:SQNM) issued its quarterly earnings data on Wednesday, May, 4th. The biotechnology company reported ($0.11) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.10) by $0.01. The biotechnology company had revenue of $27.57 million for the quarter, compared to analyst estimates of $27.85 million. Sequenom's revenue was down 27.1% compared to the same quarter last year. During the same period last year, the firm posted $0.11 earnings per share. View Sequenom's Earnings History.

Who are some of Sequenom's key competitors?

Has Sequenom been receiving favorable news coverage?

News coverage about SQNM stock has trended somewhat positive recently, according to Accern Sentiment. Accern ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sequenom earned a daily sentiment score of 0.20 on Accern's scale. They also gave news headlines about the biotechnology company an impact score of 46.46 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Sequenom?

Shares of SQNM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sequenom's stock price today?

One share of SQNM stock can currently be purchased for approximately $2.39.

How big of a company is Sequenom?

Sequenom has a market capitalization of $283.80 million. Sequenom employs 434 workers across the globe.

How can I contact Sequenom?

Sequenom's mailing address is 3595 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company can be reached via phone at +1-858-2029000.

MarketBeat Community Rating for Sequenom (SQNM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  185 (Vote Outperform)
Underperform Votes:  158 (Vote Underperform)
Total Votes:  343
MarketBeat's community ratings are surveys of what our community members think about Sequenom and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sequenom (NASDAQ:SQNM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Sequenom (NASDAQ:SQNM) Consensus Price Target History

Price Target History for Sequenom (NASDAQ:SQNM)

Sequenom (NASDAQ:SQNM) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/20/2016Jefferies GroupReiterated RatingHold$1.50 -> $0.75N/AView Rating Details
6/29/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
(Data available from 3/18/2016 forward)


Sequenom (NASDAQ:SQNM) Earnings History and Estimates Chart

Earnings by Quarter for Sequenom (NASDAQ:SQNM)

Sequenom (NASDAQ SQNM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/5/2016Q2 2016($0.09)($0.05)$27.80 million$29.29 millionViewN/AView Earnings Details
5/4/2016Q116($0.10)($0.11)$27.85 million$27.57 millionViewN/AView Earnings Details
3/2/2016Q415($0.10)($0.10)$29.35 million$27.80 millionViewN/AView Earnings Details
11/4/2015Q315($0.09)($0.08)$31.35 million$29.90 millionViewN/AView Earnings Details
8/5/2015Q215($0.05)($0.08)$35.74 million$32.77 millionViewN/AView Earnings Details
5/6/2015Q115($0.03)$0.12$38.60 million$37.80 millionViewN/AView Earnings Details
3/4/2015Q414($0.05)$0.14$41.94 million$36.80 millionViewN/AView Earnings Details
11/4/2014Q314($0.09)($0.05)$42.80 million$37.90 millionViewN/AView Earnings Details
7/29/2014Q214($0.10)($0.07)$47.80 million$39.80 millionViewN/AView Earnings Details
5/1/2014Q114($0.14)($0.13)$46.06 million$46.30 millionViewN/AView Earnings Details
2/27/2014Q413($0.16)($0.16)$47.05 million$45.13 millionViewN/AView Earnings Details
11/7/2013Q313($0.22)($0.24)$40.56 million$43.90 millionViewN/AView Earnings Details
7/24/2013Q2 2013($0.22)($0.27)$46.25 million$24.50 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.23)($0.26)$38.29 million$38.50 millionViewN/AView Earnings Details
3/7/2013Q4 2012($0.22)($0.29)$32.02 million$33.67 millionViewN/AView Earnings Details
11/8/2012Q312($0.23)($0.26)$22.91 million$22.90 millionViewN/AView Earnings Details
7/26/2012($0.21)($0.26)ViewN/AView Earnings Details
5/3/2012($0.19)($0.22)ViewN/AView Earnings Details
3/7/2012($0.18)($0.22)ViewN/AView Earnings Details
11/3/2011($0.19)($0.19)ViewN/AView Earnings Details
8/4/2011($0.17)($0.21)ViewN/AView Earnings Details
5/5/2011($0.19)($0.13)ViewN/AView Earnings Details
3/8/2011($0.21)($0.27)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.23)($0.21)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.25)($0.25)ViewN/AView Earnings Details
5/6/2010Q1 2010($0.28)($0.27)ViewN/AView Earnings Details
3/15/2010Q4 2009($0.25)($0.30)ViewN/AView Earnings Details
11/9/2009Q3 2009($0.28)($0.24)ViewN/AView Earnings Details
8/6/2009Q2 2009($0.26)($0.33)ViewN/AView Earnings Details
4/29/2009Q1 2009($0.24)($0.29)ViewN/AView Earnings Details
2/11/2009Q4 2008($0.18)($0.25)ViewN/AView Earnings Details
10/30/2008Q3 2008($0.17)($0.18)ViewN/AView Earnings Details
7/30/2008Q2 2008($0.15)($0.21)ViewN/AView Earnings Details
4/30/2008Q1 2008($0.16)($0.19)ViewN/AView Earnings Details
2/20/2008Q4 2007($0.13)($0.16)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Sequenom (NASDAQ:SQNM) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Sequenom (NASDAQ:SQNM)

No dividend announcements for this company have been tracked by

Insider Trades

Sequenom (NASDAQ SQNM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 46.03%
Insider Trades by Quarter for Sequenom (NASDAQ:SQNM)
Insider Trades by Quarter for Sequenom (NASDAQ:SQNM)

Sequenom (NASDAQ SQNM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/7/2016Corp Of America Hol LaboratoryMajor ShareholderBuy36,649,440$2.40$87,958,656.00View SEC Filing  
6/10/2016Carolyn BeaverCFOBuy30,000$1.10$33,000.00107,567View SEC Filing  
6/9/2016Carolyn BeaverCFOBuy10,000$1.10$11,000.00104,067View SEC Filing  
6/9/2016Jeffrey D LintonSVPBuy5,000$1.10$5,500.0042,853View SEC Filing  
6/8/2016Den Boom Dirk VanCEOBuy40,000$1.09$43,600.00173,044View SEC Filing  
5/11/2016Daniel S Md GrosuCMOBuy30,000$1.11$33,300.0051,424View SEC Filing  
5/6/2016Den Boom Dirk VanCEOBuy30,000$1.13$33,900.00133,044View SEC Filing  
5/6/2016Jeffrey D LintonSVPBuy10,000$1.15$11,500.0037,853View SEC Filing  
1/4/2016Camber Capital Management LlcMajor ShareholderBuy665,435$1.62$1,078,004.70View SEC Filing  
12/16/2015Camber Capital Management LlcMajor ShareholderBuy468,000$1.30$608,400.00View SEC Filing  
12/15/2015Camber Capital Management LlcMajor ShareholderBuy20,000$1.41$28,200.00View SEC Filing  
12/14/2015Camber Capital Management LlcMajor ShareholderBuy448,000$1.30$582,400.00View SEC Filing  
12/10/2015Camber Capital Management LlcMajor ShareholderBuy791,565$1.30$1,029,034.50View SEC Filing  
10/8/2015Camber Capital Management LlcMajor ShareholderBuy1,650,090$1.96$3,234,176.40View SEC Filing  
3/10/2015William J WelchCEOBuy10,000$3.65$36,500.00View SEC Filing  
3/9/2015Carolyn BeaverCFOBuy10,000$3.60$36,000.00View SEC Filing  
3/6/2015Jeffrey D LintonSVPBuy10,000$3.64$36,400.00View SEC Filing  
11/29/2012Goldman Myla LaiDirectorBuy4,000$4.59$18,360.00View SEC Filing  
11/26/2012John A FazioDirectorBuy2,000$4.45$8,900.00View SEC Filing  
8/8/2012Charles P SlacikDirectorBuy5,000$3.24$16,200.00View SEC Filing  
8/7/2012John A FazioDirectorBuy2,000$3.33$6,660.00View SEC Filing  
(Data available from 1/1/2013 forward)


Sequenom (NASDAQ SQNM) News Headlines

Sequenom (SQNM) & Varex Imaging (VREX) Financial AnalysisSequenom (SQNM) & Varex Imaging (VREX) Financial Analysis - November 10 at 5:48 PM
Financial Survey: Sequenom (SQNM) versus Oxford Immunotec Global PLC (OXFD)Financial Survey: Sequenom (SQNM) versus Oxford Immunotec Global PLC (OXFD) - October 15 at 2:40 PM
LabCorp (LH) Q4 Earnings: Whats in the Cards for the Stock?LabCorp (LH) Q4 Earnings: What's in the Cards for the Stock? - October 6 at 12:27 PM
Analyzing Sequenom (SQNM) and Oxford Immunotec Global PLC (OXFD)Analyzing Sequenom (SQNM) and Oxford Immunotec Global PLC (OXFD) - September 28 at 2:48 PM
Alphatec Holdings (ATEC) & Sequenom (SQNM) Head to Head ContrastAlphatec Holdings (ATEC) & Sequenom (SQNM) Head to Head Contrast - September 19 at 6:10 PM
Eton Pharmaceuticals Appoints Paul V. Maier to its Board of DirectorsEton Pharmaceuticals Appoints Paul V. Maier to its Board of Directors - September 15 at 9:17 AM
Illumina Files New Patent Infringement Suit Against Premaitha Health plcIllumina Files New Patent Infringement Suit Against Premaitha Health plc - September 7 at 9:22 AM
Comparing Sequenom (SQNM) & Cepheid (CPHD)Comparing Sequenom (SQNM) & Cepheid (CPHD) - August 28 at 6:18 PM
Sequenom (SQNM) and Cepheid (CPHD) Financial SurveySequenom (SQNM) and Cepheid (CPHD) Financial Survey - August 26 at 4:12 AM
Comparing Sequenom (SQNM) and Myriad Genetics (MYGN)Comparing Sequenom (SQNM) and Myriad Genetics (MYGN) - August 25 at 1:02 PM
Cepheid (CPHD) vs. Sequenom (SQNM) Head-To-Head AnalysisCepheid (CPHD) vs. Sequenom (SQNM) Head-To-Head Analysis - August 18 at 10:46 AM
Cepheid (CPHD) vs. Sequenom (SQNM) Financial AnalysisCepheid (CPHD) vs. Sequenom (SQNM) Financial Analysis - August 17 at 12:26 PM
Illumina notches win in prenatal testing patent fightIllumina notches win in prenatal testing patent fight - June 28 at 1:03 AM
Apostle Inc Announces New Board Member and AdvisorsApostle Inc Announces New Board Member and Advisors - June 15 at 3:47 PM
LabCorp seeks to acquire NC clinical trials firm PPD, per report - Triad Business JournalLabCorp seeks to acquire NC clinical trials firm PPD, per report - Triad Business Journal - February 8 at 6:16 AM
LLabCorp: Reimbursement Scenario a Drag Amid Other WoesLLabCorp: Reimbursement Scenario a Drag Amid Other Woes - January 9 at 8:03 AM

SEC Filings

Sequenom (NASDAQ:SQNM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Sequenom (NASDAQ:SQNM) Income Statement, Balance Sheet and Cash Flow Statement


Sequenom (NASDAQ SQNM) Stock Chart for Sunday, March, 18, 2018

Loading chart…

This page was last updated on 3/18/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.